Pivotal pharmacokinetic trial to compare topical diclofenac 2% (Pennsaid 2%) and topical diclofenac 1.5% (Pennsaid)

Trial Profile

Pivotal pharmacokinetic trial to compare topical diclofenac 2% (Pennsaid 2%) and topical diclofenac 1.5% (Pennsaid)

Completed
Phase of Trial: Phase I

Latest Information Update: 01 May 2014

At a glance

  • Drugs Diclofenac (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Pharmacokinetics; Registrational
  • Most Recent Events

    • 01 May 2014 Results will be presented at American Pain Society Annual Scientific Meeting.
    • 15 Aug 2013 Trial results have been submitted to the US FDA by Mallinckrodt, the US licensing partner, according to a Nuvo Research media release.
    • 23 Jul 2013 Status changed from recruiting to completed, according to a Nuvo Research media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top